News
-
-
-
-
-
-
-
PRESS RELEASE
NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
NanoViricides, Inc. announces successful safety and tolerability results of broad-spectrum antiviral drug NV-387 in juvenile animal model study, paving the way for pediatric clinical trials -
-
-